← FDA DRUG APPROVALS

FDA ANDA · ANDA062889

CLINDAMYCIN PHOSPHATE

Sponsor: HIKMA

APPLICATION
ANDA062889
TYPE
ANDA
ORIGINAL APPROVAL
1988-04-25
LATEST ACTION
1995-11-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CLINDAMYCIN PHOSPHATEPrescription
CLINDAMYCIN PHOSPHATE EQ 150MG BASE/ML · INJECTABLE · INJECTION

Approval history

1995-11-14Manufacturing (CMC) · Supplement 8AP
1994-08-30Manufacturing (CMC) · Supplement 7AP
1993-04-26Labeling · Supplement 6AP
1991-06-18Labeling · Supplement 5AP
1990-06-26Manufacturing (CMC) · Supplement 3AP
1989-02-21Manufacturing (CMC) · Supplement 2AP
1988-09-29Manufacturing (CMC) · Supplement 1AP
1988-04-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →